Sulzer AG to Spin-Off Applicator Systems To Be Renamed Medmix Call Transcript
Ladies and gentlemen, welcome to the Sulzer conference call on the spin-off of APS. I am Sandra, the Chorus Call operator. The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to Christoph Ladner, Head of Investor Relations. Please go ahead, sir.
Good afternoon, and welcome to Sulzer's conference call on the spin-off of APS. Today with me is our CEO, Greg Guillaume; and our CFO, Jill Lee.
For this call, we have prepared a presentation, which you can find on our homepage. As always, I want to draw your attention on the disclaimer on Slide #2.
The call contains forward-looking statements, including, but not limited to, projections of financial developments, market activities, future performance of products and solutions or planned transactions containing risks and uncertainties. These forward-looking statements are subject to change based on known or unknown risks and various other factors, which could cause the actual results, performance or
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |